1. Academic Validation
  2. Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides

Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides

  • Nat Chem Biol. 2022 Oct;18(10):1076-1086. doi: 10.1038/s41589-022-01061-z.
Fu-Long Li  # 1 2 Vivian Fu  # 1 2 Guangbo Liu  # 1 2 Tracy Tang 3 Andrei W Konradi 3 Xiao Peng 3 4 Esther Kemper 5 Benjamin F Cravatt 5 J Matthew Franklin 1 2 Zhengming Wu 1 2 Joshua Mayfield 1 Jack E Dixon 1 William H Gerwick 6 Kun-Liang Guan 7 8
Affiliations

Affiliations

  • 1 Department of Pharmacology, University of California San Diego, La Jolla, CA, USA.
  • 2 Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • 3 Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA.
  • 4 Vivace Therapeutics, Inc., San Mateo, CA, USA.
  • 5 Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
  • 6 Genus IntelliGen, Windsor, WI, USA.
  • 7 Department of Pharmacology, University of California San Diego, La Jolla, CA, USA. [email protected].
  • 8 Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. [email protected].
  • # Contributed equally.
Abstract

The Hippo pathway plays a key role in development, organ size control and tissue homeostasis, and its dysregulation contributes to Cancer. The LATS tumor suppressor kinases phosphorylate and inhibit the YAP/TAZ transcriptional co-activators to suppress gene expression and cell growth. Through a screen of Marine natural products, we identified microcolin B (MCB) as a Hippo activator that preferentially kills YAP-dependent Cancer cells. Structure-activity optimization yielded more potent MCB analogs, which led to the identification of phosphatidylinositol transfer proteins α and β (PITPα/β) as the direct molecular targets. We established a critical role of PITPα/β in regulating LATS and YAP. Moreover, we showed that PITPα/β influence the Hippo pathway via plasma membrane phosphatidylinositol-4-phosphate. This study uncovers a previously unrecognized role of PITPα/β in Hippo pathway regulation and as potential Cancer therapeutic targets.

Figures
Products